Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Merrimack Pharmaceuticals (MACK) News Today

Merrimack Pharmaceuticals logo

MACK Latest News

Merrimack Pharma Stock Price History
MACK Merrimack Pharmaceuticals, Inc.
Merrimack Reports Full Year 2023 Financial Results
MACK Mar 2024 14.000 put
MACK Mar 2024 4.000 put
MACK Feb 2024 16.000 put
Ipsen drug approved by FDA for early pancreatic cancer
Merrimack Pharmaceuticals Inc MACK
Merrimack Reports Third Quarter 2023 Financial Results
Merrimack Reports Second Quarter 2023 Financial Results
Get Merrimack Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MACK and its competitors with MarketBeat's FREE daily newsletter.

MACK Media Mentions By Week

MACK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MACK
News Sentiment

0.92

0.54

Average
Medical
News Sentiment

MACK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MACK Articles
This Week

0

0

MACK Articles
Average Week

Get Merrimack Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MACK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:MACK) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners